Cataracts affect RNFL and OCT output

Article

The presence of cataracts could influence optical coherence tomography (OCT) signal strength (SS) and peripapillary retinal nerve fibre layer (RNFL) thickness measurements

The presence of cataracts could influence optical coherence tomography (OCT) signal strength (SS) and peripapillary retinal nerve fibre layer (RNFL) thickness measurements, according to a study published in the Journal of Glaucoma.

Dr Jean Mwanza

et al.

, Basom Palmer Eye Institute, University of Miami, Leonard Miller School of Medicine, Miami, Florida, USA, studied 45 cataract patients, 23 of which had glaucoma.

Cataracts were graded with the Lens Opacities Classification System III. Stratus OCT scans were used to measure peripapillary RNFL before and after cataract surgery.

The results revealed a significant postoperative difference in RNFL thickness in patients with a lower preoperative RNFL thickness and SS. The findings also demonstrated no significant difference in RNFL thickness change between cataract patients and patients with both glaucoma and cataract.

The investigation suggests that peripapillary RNFL measurements, especially if SS is weaker, should be interpreted with care in glaucomatous eyes, as cataracts could affect them.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.